Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Alkem’s US Business Doubles And Continues To Grow
As Company Received 10 ANDA Approvals In Q4 FY21
May 28 2021
•
By
Akriti Seth
Alkem’s domestic business continues to recover and grow significantly • Source: Alamy
More from Products
More from Generics Bulletin